ICreate_Logo_White-01-1

ReadyDetect:
Next-Generation Diagnostics Competition

Target Product Profile: Point-of-Care / CLIA-Waived and OTC / At-Home Use Pathogen Diagnostics

Attribute

Minimal

Ideal

Intended use

  • Rapid detection of specific disease/condition

Target population being tested

  • General population to make informed decisions about health or during periods of heightened disease threats

  • General population with special emphasis on underserved and resource limited areas

Use setting

  • Home, remote-use, community centers, urgent care, mobile units, ER

  • Home, remote-use, community centers, urgent care, mobile units, ER

Product description

  • Small, hand-held meter and disposable test strip

  • Meter price <$10

  • Disposable test price <$0.50

  • Multiplexing capability for 2 to 4, including controls 

  • Ease of use: simple intuitive procedure with minimal training

  • Ease of scale-up and manufacturing

  • Battery operated meter

  • Packaging: minimal, moisture proof and lightweight

  • Product readily accessible through local distribution channels

  • Shelf life – 3 months at RT and RH < 50%

    • Shelf life – transportation at ~ 60° C, for 24 hours, RH 60%

    • No change in performance when exposed to direct sunlight for more than 1 hour

  • No meter required 

  • Disposable test price < $0.50

  • Multiplexing 4 to 6+ including controls

  • Ease of use: simple intuitive procedure with minimal training

  • Results visualization and data transfer using smart phone

  • Scalable production using locally sourced material

  • No power requirement

  • Packaging: moisture proof, lightweight and biodegradable. 

  • Available in multiple local languages, with pictorial instructions for non-literate users

  • Shelf life – 24 months at RT at and RH <80%

    • Shelf life – transportation at ~ 60° C, for 24 hours, RH 80%

Performance characteristics 

  • Sensitivity: > 90% for influenza / > 95% for biothreats

  • Specificity: > 95% for influenza / > 98% for biothreats

  • Sensitivity and specificity comparable to FDA approved methods, gold standard, and/or ability to detect targets within the diagnostic window of opportunity.

  • Time to result: < 30 mins 

  • Sample type(s): Easy to collect samples (capillary blood, saliva, nasal swabs)

  • Prevention of sample contamination of the meter

  • Sample processing: minimal

  • Four or fewer steps from sample to answer

  • Performance unaffected by high temperatures (40° C) and relative humidity (>85%) for 12 months

  • No cold chain storage

  • Sensitivity: >95% for the target analyte(s) 

  • Specificity: >98% 

  • Sensitivity and specificity compared to FDA approved methods

  • Time to result < 10 mins 

  • Sample type(s): Easy to collect samples (finger-stick blood, urine, saliva, nasal swabs)

  • Ability to process multiple specimen types

  • Sample processing: none

  • Two steps from sample to answer

  • Performance unaffected by high temperatures (40° C) and relative humidity (>85%) for 24 months

  • No cold chain storage

Safety

  • Must not use toxic materials in test or in sample prep

  • Safe for handling in non-laboratory settings

  • Safely disposable and/or easily decontaminated

  • Must not use toxic materials in test or in sample prep

  • Safe for handling in non-laboratory settings

  • Safely disposable and/or easily decontaminated

User experience

  • Simple, intuitive use

  • Clear instructions for valid use

  • Results are easily interpretable

  • Simple, intuitive use

  • Clear visual readout

  • Results are easily interpretable

Regulatory and quality

  • CE mark and/or FDA clearance/approval

  • CLIA-waived or CLIA-waivable

  • ISO 13485 certification and batch–to-batch consistency

  • CE mark and FDA clearance/approval

  • CLIA-waived or CLIA-waivable

  • ISO 13485 certification and batch-to-batch consistency

Competitive landscape

  • Lateral flow devices

  • Lateral flow devices, POC molecular tests

Download PDF Version